share_log

仁度生物(688193.SH):2023年净利预减90%到85%

Jindu Biotech (688193.SH): Pre-cut net profit by 90% to 85% in 2023

Gelonghui Finance ·  Jan 30 18:01

Gelonghui, January 30丨Rendu Biotech (688193.SH) announced its 2023 annual results forecast. According to preliminary estimates by the finance department, the company expects to achieve net profit attributable to owners of the parent company in 2023 of 2.3 million yuan to 3.4 million yuan. Compared with the same period of the previous year (statutory disclosure data), it will decrease by 21.03 to 19.93 million yuan, a year-on-year decrease of 90% to 85%.

Net profit attributable to owners of the parent company in 2023, after deducting non-recurring profit and loss, is expected to be -13.47 million yuan to -12.37 million yuan. Compared with the same period of the previous year (statutory disclosure data), it will decrease by 18.41 million yuan to 17.31 million yuan, a decrease of 373% to 350% over the previous year.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment